LA JOLLA, CA—A collaborative study by researchers at the Salk Institute for Biological Studies uncovered that the tumor suppressor p53, which made its name as “guardian of the genome,” not only stops cells that could become cancerous in their tracks but also controls somatic cell reprogramming.
LA JOLLA, CA—Rather than sticking to a single DNA script, human brain cells harbor astonishing genomic variability, according to scientists at the Salk Institute for Biological Studies. The findings, to be published in the Aug. 5, 2009, advance online edition of Nature, could help explain brain development and individuality, as well as lead to a better understanding of neurological disease.
LA JOLLA, CA—Of all the qualities that distinguish humans from other species, how we learn is one of the most significant. In the July 17, 2009 issue of the journal Science, researchers who are at the forefront of neuroscience, psychology, education, and machine learning have synthesized a new science of learning that is already reshaping how we think about learning and creating opportunities to re-imagine the classroom for the 21st century.
LA JOLLA, CA—Just like a conductor cueing musicians in an orchestra, Fgf10, a member of the fibroblast growth factor (Ffg) family of morphogens, lets brain stem cells know that the moment to get to work has arrived, ensuring that they hit their first developmental milestone on time, report scientists at the Salk Institute for Biological Studies in the July 16, 2009, edition of the journal Neuron.
SAN DIEGO, CA—The Salk Institute for Biological Sciences today announced the establishment of the Irwin M. Jacobs Presidential Chair based on an endowment from Qualcomm and Qualcomm’s employees. The Presidential Chair commemorates Qualcomm founder Dr. Irwin Jacobs’ recent decision to step down as chairman of Qualcomm’s Board of Directors and recognizes his ongoing dedicated leadership of the Salk Institute’s Board of Trustees. Dr. Jacobs continues to serve as a member of Qualcomm’s Board of Directors and in that capacity continues to provide his vision and guidance.
LA JOLLA, CA—A $3.8 million grant from the National Eye Institute (NEI) of the National Institutes of Health places the Salk Institute among one of seven NEI-designated centers focused exclusively on the basic research of vision, and is the first basic science facility created by the NEI in nearly a decade.
LA JOLLA, CA—Although the fact that we generate new brain cells throughout life is no longer disputed, their purpose has been the topic of much debate. Now, an international collaboration of researchers made a big leap forward in understanding what all these newborn neurons might actually do. Their study, published in the July 10, 2009, issue of the journal Science, illustrates how these young cells improve our ability to navigate our environment.
LA JOLLA, CA—A tightly controlled system of checks and balances ensures that a powerful tumor suppressor called p53 keeps a tight lid on unchecked cell growth but doesn’t wreak havoc in healthy cells. In their latest study, scientists at the Salk Institute for Biological Studies suggest just how finely tuned the system is and how little it takes to tip the balance.
LA JOLLA—The Salk Institute for Biological Studies garnered the top discovery spot in the latest international ranking in the category “Neuroscience and Behavior” by Science Watch, a scientific organization that measures the citation impact of research published worldwide. Citations are an important measure of the value and influence of scientists’ work and reflect the impact made by that work on scientific understanding.
LA JOLLA, CA—Alcohol’s inebriating effects are familiar to everyone. But the molecular details of alcohol’s impact on brain activity remain a mystery. A new study by researchers at the Salk Institute for Biological Studies brings us closer to understanding how alcohol alters the way brain cells work.
LA JOLLA, CA-Experiment after experiment confirms that a diet on the brink of starvation expands lifespan in mice and many other species. But the molecular mechanism that links nutrition and survival is still poorly understood. Now, researchers at the Salk Institute for Biological Studies have identified a pivotal role for two enzymes that work together to determine the health benefits of diet restriction.
La Jolla, CA—Obesity is probably the most important factor in the development of insulin resistance, but science’s understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two. Their findings, to be published in the June 21, 2009 advance online edition of the journal Nature, explain how obesity sets the stage for diabetes and why thin people can become insulin-resistant.
LA JOLLA, CA-People who suffer from Peutz-Jeghers syndrome, a rare inherited cancer syndrome, develop gastrointestinal polyps and are predisposed to colon cancer and other tumor types. Carefully tracing the cellular chain-of-command that links nutrient intake to cell growth (and which is interrupted in Peutz-Jeghers syndrome), allowed researchers at the Salk Institute for Biological Studies to exploit the tumors' weak spot.
La Jolla, CA—A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
La Jolla, CA—Salk Professor Inder M. Verma, Ph.D., one of the world’s leading authorities on the development and use of engineered viruses for gene therapy, has been named the 2009 recipient of the American Society of Gene Therapy’s Outstanding Achievement Award. The award recognizes an ASGT member who has conducted groundbreaking research or achieved a lifetime of significant scientific contributions to the field of gene therapy. Verma is only the second scientist honored with the society’s Outstanding Achievement Award, which debuted in 2008.
La Jolla-More than three years ago, while serving as president-elect and then president of the American Association for Cancer Research (AACR), Salk scientist Geoff Wahl had an epiphany: cancer research needed a grassroots American fundraising movement reminiscent of the polio-inspired March of Dimes.
La Jolla, CA-Our genome is a patchwork of neighborhoods that couldn’t be more different: Some areas are hustling and bustling with gene activity, while others are sparsely populated and in perpetual lock-down. Breaking down just a few of the molecular fences that separate them blurs the lines and leads to the inactivation of at least two tumor suppressor genes, according to researchers at the Salk Institute for Biological Studies.
La Jolla, CA—Dr. Tatyana Sharpee, an assistant professor in the Laboratory for Computational Biology, has been named a 2009 McKnight Scholar. She will receive a grant of $225,000 over a three-year period to study “Discrete representation of visual shapes in the brain.”
La Jolla, CA — The Salk Institute for Biological Studies has been awarded a $6.6 million grant – the largest single award in the latest competition — by the California Institute Regenerative Medicine (CIRM) for research aimed at translating basic science into clinical cures. The funds are part of $67.7 million Early Translational Grants CIRM provided to 15 research organizations on Wednesday.
La Jolla, CA – Salk researcher Marc R. Montminy, M.D., Ph.D., a professor in the Clayton Foundation Laboratories for Peptide Biology, has been elected a member of the National Academy of Sciences, the nation’s most prestigious honorary society for scientists. The Academy made the announcement today during its 146th annual meeting in Washington, DC.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
